Tag: Dr Robert A Wood

Test Tubes

FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...

Phase 2 study of candidate from Aravax will commence in the US and Australia.
Eggs

Following OIT, Certain Egg Allergy Patients Likely to Consume and Tolerate...

Subjects achieving sustained unresponsiveness to egg following four years of oral immunotherapy likely to consume and tolerate eggs five years later.
Skin Prick Testing

Food Allergy Immunotherapy Advances Presented at AAAAI Meeting

Here's a quick recap from this morning's AAAAI press release.